Brian M. Hahn
2021
In 2021, Brian M. Hahn earned a total compensation of $1.1M as Senior Vice President and Chief Financial Officer at GlycoMimetics, a 7% decrease compared to previous year.
Compensation breakdown
| Bonus | $202,500 |
|---|---|
| Non-Equity Incentive Plan | $164,562 |
| Option Awards | $186,732 |
| Salary | $428,622 |
| Stock Awards | $131,445 |
| Other | $8,700 |
| Total | $1,122,561 |
Hahn received $428.6K in salary, accounting for 38% of the total pay in 2021.
Hahn also received $202.5K in bonus, $164.6K in non-equity incentive plan, $186.7K in option awards, $131.4K in stock awards and $8.7K in other compensation.
Rankings
In 2021, Brian M. Hahn's compensation ranked 8,390th out of 12,415 executives tracked by ExecPay. In other words, Hahn earned more than 32.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,390 out of 12,415 | 32nd |
Division Manufacturing | 3,719 out of 5,505 | 32nd |
Major group Chemicals And Allied Products | 1,652 out of 2,375 | 30th |
Industry group Drugs | 1,470 out of 2,096 | 30th |
Industry Pharmaceutical Preparations | 1,095 out of 1,546 | 29th |
Source: SEC filing on April 11, 2022.
Hahn's colleagues
We found three more compensation records of executives who worked with Brian M. Hahn at GlycoMimetics in 2021.
News
GlycoMimetics CEO Harout Semerjian's 2023 pay jumps 67% to $2.4M
April 1, 2024
GlycoMimetics CEO Harout Semerjian's 2022 pay falls 50% to $1.4M
April 21, 2023
GlycoMimetics CEO Harout Semerjian receives $2.9M in 2021
April 11, 2022
GlycoMimetics CEO Rachel King's 2018 pay jumps 105% to $3.2M
April 10, 2019